Approval · Notice of Compliance 1531 · 2000

PANECTYL: Notice of Compliance 1531

Issued November 14, 2000

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 1531
Date: November 14, 2000
Company: Aventis Pharma Inc.Laval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Antipruritic-antihistaminic

Products in this notice

Brand	DIN	Status today
PANECTYL	01926306	Cancelled Post Market
PANECTYL	01926292	Cancelled Post Market
PANECTYL	01926446	Cancelled Post Market

Medicinal ingredients

TRIMEPRAZINE TARTRATE 2.5 MG per TAB
TRIMEPRAZINE TARTRATE 5 MG per TAB
TRIMEPRAZINE TARTRATE 2.5 MG per 5ML